2022-02-112023-02-282023-02-28false13908987DOCBOT LABS LTD2023-11-08iso4217:GBPxbrli:pure139089872022-02-11139089872023-02-28139089872022-02-112023-02-28139089872022-02-10139089872022-02-10139089872022-02-102022-02-1013908987bus:SmallEntities2022-02-112023-02-2813908987bus:AuditExempt-NoAccountantsReport2022-02-112023-02-2813908987bus:FullAccounts2022-02-112023-02-2813908987bus:PrivateLimitedCompanyLtd2022-02-112023-02-2813908987core:WithinOneYear2023-02-2813908987core:AfterOneYear2023-02-2813908987core:WithinOneYear2022-02-1013908987core:AfterOneYear2022-02-1013908987core:ShareCapital2023-02-2813908987core:SharePremium2023-02-2813908987core:RevaluationReserve2023-02-2813908987core:OtherReservesSubtotal2023-02-2813908987core:RetainedEarningsAccumulatedLosses2023-02-2813908987core:ShareCapital2022-02-1013908987core:SharePremium2022-02-1013908987core:RevaluationReserve2022-02-1013908987core:OtherReservesSubtotal2022-02-1013908987core:RetainedEarningsAccumulatedLosses2022-02-1013908987core:LandBuildings2023-02-2813908987core:PlantMachinery2023-02-2813908987core:Vehicles2023-02-2813908987core:FurnitureFittings2023-02-2813908987core:OfficeEquipment2023-02-2813908987core:NetGoodwill2023-02-2813908987core:IntangibleAssetsOtherThanGoodwill2023-02-2813908987core:ListedExchangeTraded2023-02-2813908987core:UnlistedNon-exchangeTraded2023-02-2813908987core:LandBuildings2022-02-1013908987core:PlantMachinery2022-02-1013908987core:Vehicles2022-02-1013908987core:FurnitureFittings2022-02-1013908987core:OfficeEquipment2022-02-1013908987core:NetGoodwill2022-02-1013908987core:IntangibleAssetsOtherThanGoodwill2022-02-1013908987core:ListedExchangeTraded2022-02-1013908987core:UnlistedNon-exchangeTraded2022-02-1013908987core:LandBuildings2022-02-112023-02-2813908987core:PlantMachinery2022-02-112023-02-2813908987core:Vehicles2022-02-112023-02-2813908987core:FurnitureFittings2022-02-112023-02-2813908987core:OfficeEquipment2022-02-112023-02-2813908987core:NetGoodwill2022-02-112023-02-2813908987core:IntangibleAssetsOtherThanGoodwill2022-02-112023-02-2813908987core:ListedExchangeTraded2022-02-112023-02-2813908987core:UnlistedNon-exchangeTraded2022-02-112023-02-2813908987core:MoreThanFiveYears2022-02-112023-02-2813908987core:Non-currentFinancialInstruments2023-02-2813908987core:Non-currentFinancialInstruments2022-02-1013908987dpl:CostSales2022-02-112023-02-2813908987dpl:DistributionCosts2022-02-112023-02-2813908987core:LandBuildings2022-02-112023-02-2813908987core:PlantMachinery2022-02-112023-02-2813908987core:Vehicles2022-02-112023-02-2813908987core:FurnitureFittings2022-02-112023-02-2813908987core:OfficeEquipment2022-02-112023-02-2813908987dpl:AdministrativeExpenses2022-02-112023-02-2813908987core:NetGoodwill2022-02-112023-02-2813908987core:IntangibleAssetsOtherThanGoodwill2022-02-112023-02-2813908987dpl:GroupUndertakings2022-02-112023-02-2813908987dpl:ParticipatingInterests2022-02-112023-02-2813908987dpl:GroupUndertakingscore:ListedExchangeTraded2022-02-112023-02-2813908987core:ListedExchangeTraded2022-02-112023-02-2813908987dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-02-112023-02-2813908987core:UnlistedNon-exchangeTraded2022-02-112023-02-2813908987dpl:CostSales2022-02-102022-02-1013908987dpl:DistributionCosts2022-02-102022-02-1013908987core:LandBuildings2022-02-102022-02-1013908987core:PlantMachinery2022-02-102022-02-1013908987core:Vehicles2022-02-102022-02-1013908987core:FurnitureFittings2022-02-102022-02-1013908987core:OfficeEquipment2022-02-102022-02-1013908987dpl:AdministrativeExpenses2022-02-102022-02-1013908987core:NetGoodwill2022-02-102022-02-1013908987core:IntangibleAssetsOtherThanGoodwill2022-02-102022-02-1013908987dpl:GroupUndertakings2022-02-102022-02-1013908987dpl:ParticipatingInterests2022-02-102022-02-1013908987dpl:GroupUndertakingscore:ListedExchangeTraded2022-02-102022-02-1013908987core:ListedExchangeTraded2022-02-102022-02-1013908987dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-02-102022-02-1013908987core:UnlistedNon-exchangeTraded2022-02-102022-02-1013908987core:NetGoodwill2023-02-2813908987core:IntangibleAssetsOtherThanGoodwill2023-02-2813908987core:LandBuildings2023-02-2813908987core:PlantMachinery2023-02-2813908987core:Vehicles2023-02-2813908987core:FurnitureFittings2023-02-2813908987core:OfficeEquipment2023-02-2813908987core:AfterOneYear2023-02-2813908987core:WithinOneYear2023-02-2813908987core:ListedExchangeTraded2023-02-2813908987core:UnlistedNon-exchangeTraded2023-02-2813908987core:ShareCapital2023-02-2813908987core:SharePremium2023-02-2813908987core:RevaluationReserve2023-02-2813908987core:OtherReservesSubtotal2023-02-2813908987core:RetainedEarningsAccumulatedLosses2023-02-2813908987core:NetGoodwill2022-02-1013908987core:IntangibleAssetsOtherThanGoodwill2022-02-1013908987core:LandBuildings2022-02-1013908987core:PlantMachinery2022-02-1013908987core:Vehicles2022-02-1013908987core:FurnitureFittings2022-02-1013908987core:OfficeEquipment2022-02-1013908987core:AfterOneYear2022-02-1013908987core:WithinOneYear2022-02-1013908987core:ListedExchangeTraded2022-02-1013908987core:UnlistedNon-exchangeTraded2022-02-1013908987core:ShareCapital2022-02-1013908987core:SharePremium2022-02-1013908987core:RevaluationReserve2022-02-1013908987core:OtherReservesSubtotal2022-02-1013908987core:RetainedEarningsAccumulatedLosses2022-02-1013908987core:NetGoodwill2022-02-1013908987core:IntangibleAssetsOtherThanGoodwill2022-02-1013908987core:LandBuildings2022-02-1013908987core:PlantMachinery2022-02-1013908987core:Vehicles2022-02-1013908987core:FurnitureFittings2022-02-1013908987core:OfficeEquipment2022-02-1013908987core:AfterOneYear2022-02-1013908987core:WithinOneYear2022-02-1013908987core:ListedExchangeTraded2022-02-1013908987core:UnlistedNon-exchangeTraded2022-02-1013908987core:ShareCapital2022-02-1013908987core:SharePremium2022-02-1013908987core:RevaluationReserve2022-02-1013908987core:OtherReservesSubtotal2022-02-1013908987core:RetainedEarningsAccumulatedLosses2022-02-1013908987core:AfterOneYear2022-02-112023-02-2813908987core:WithinOneYear2022-02-112023-02-2813908987core:Non-currentFinancialInstrumentscore:CostValuation2022-02-112023-02-2813908987core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-02-112023-02-2813908987core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-02-112023-02-2813908987core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-02-112023-02-2813908987core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-02-112023-02-2813908987core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-02-112023-02-2813908987core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-02-112023-02-2813908987core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-02-112023-02-2813908987core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-02-112023-02-2813908987core:Non-currentFinancialInstrumentscore:CostValuation2023-02-2813908987core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-02-2813908987core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-02-2813908987core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-02-2813908987core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-02-2813908987core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-02-2813908987core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-02-2813908987core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-02-2813908987core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-02-2813908987core:Non-currentFinancialInstrumentscore:CostValuation2022-02-1013908987core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-02-1013908987core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-02-1013908987core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-02-1013908987core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-02-1013908987core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-02-1013908987core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-02-1013908987core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-02-1013908987core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-02-1013908987bus:Director12022-02-112023-02-28

DOCBOT LABS LTD

Registered Number
13908987
(England and Wales)

Unaudited Financial Statements for the Period ended
28 February 2023

DOCBOT LABS LTD
Company Information
for the period from 11 February 2022 to 28 February 2023

Director

J Davenport

Registered Address

86-90 Paul Street
London
EC2A 4NE

Registered Number

13908987 (England and Wales)
DOCBOT LABS LTD
Statement of Financial Position
28 February 2023

Notes

2023

£

£

Fixed assets
Tangible assets82,195
2,195
Current assets
Debtors95,662
Cash at bank and on hand413,363
419,025
Creditors amounts falling due within one year10(7,675)
Net current assets (liabilities)411,350
Total assets less current liabilities413,545
Net assets413,545
Capital and reserves
Called up share capital1
Share premium562,780
Profit and loss account(149,236)
Shareholders' funds413,545
The financial statements were approved and authorised for issue by the Director on 8 November 2023, and are signed on its behalf by:
J Davenport
Director
Registered Company No. 13908987
DOCBOT LABS LTD
Notes to the Financial Statements
for the period ended 28 February 2023

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard. Incorporation and commencement of trade: The company was incorporated on 11 February 2022 and commenced trading as of that date.
3.Principal activities
The principal activity of the company in the period under review was that of Software development.
4.Basis of measurement used in financial statements
The financial statements have been prepared under the historical cost convention.
5.Accounting policies
Functional and presentation currency policy
The financial statements are presented in pound sterling (£), which is the company's functional currency, and figures are rounded to the nearest whole pound.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The company has not generated any revenue for the period under review.
Property, plant and equipment policy
Tangible assets are stated at cost (or deemed cost), less accumulated depreciation and accumulated impairment losses. Cost includes the original purchase price, costs directly attributable to bringing the asset to its working condition for its intended use, dismantling and restoration costs. Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Straight line (years)
Office Equipment4
Taxation policy
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax policy
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Leases policy
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.
Employee benefits policy
Contributions to defined contribution plans are expensed in the period to which they relate.
Valuation of financial instruments policy
The Company has chosen to adopt the Sections 11 and 12 of FRS 102 in respect of financial instruments. The Company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in non puttable ordinary shares. Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or financed at a rate of interest that is not a market rate or in case of an out right short term loan not at market rate, the financial asset or liability is measured, initially, at the present value of the future cash flow discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost. Financial assets and liabilities are offset and the net amount reported in the Statement of Financial Position when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. Cash and cash equivalents comprise cash on hand and demand deposits and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk to changes in value.
Going concern
The financial statements have been prepared on a going concern basis. The company incurred losses during the year, however, the director has a reasonable expectation that the company has sufficient reserves in order to trade effectively for a period of at least 12 months from the reporting period end date and believes that the company has sufficient cash reserves to meet its obligations, if and when, they become due. The director is therefore of the opinion that the company should continue to adopt the going concern basis of accounting in preparing the financial statements.
6.Critical estimates and judgements
There are no significant judgements or estimates applied to the figures contained within these financial statements.
7.Employee information

2023
Average number of employees during the year2
8.Property, plant and equipment

Office Equipment

Total

££
Cost or valuation
Additions2,8052,805
At 28 February 232,8052,805
Depreciation and impairment
Charge for year610610
At 28 February 23610610
Net book value
At 28 February 232,1952,195
At 10 February 22--
9.Debtors

2023

£
Other debtors1,940
Prepayments and accrued income3,722
Total5,662
10.Creditors within one year

2023

£
Trade creditors / trade payables81
Bank borrowings and overdrafts2,553
Taxation and social security5,041
Total7,675